Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a case report

被引:8
|
作者
Wang, Ping [1 ]
Wang, Zhaoming
Kong, Yunyi
Xu, Aie
机构
[1] Anhui Med Univ, Affiliated Hosp Hangzhou 3, Dept Dermatol, Hangzhou 310009, Zhejiang, Peoples R China
关键词
EUROPEAN ORGANIZATION; MARKER BDCA-2; CLASSIFICATION; EXPRESSION; ENTITY; TUMOR; SKIN;
D O I
10.1111/j.1365-4632.2009.03777.x
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
A previously healthy 44-year-old Chinese man presented with a nonitching, painless, skin lesion on the right lateral abdomen of 1-year duration. This lesion presented initially as a nodule of approximately 0.5 cm in diameter, which eventually grew to the size of an egg by August 2006. The patient had experienced no systemic symptoms, and his past medical and family history were noncontributory. Physical examination was normal except for the skin lesion. Peripheral lymph nodes were not palpable. Skin examination showed a lobulated, contusiform, brownish, infiltrated nodule with a wide base on the right lateral abdomen (Fig. 1). Histologic examination of a biopsy specimen taken from the lesion revealed the presence of a dense dermal lymphomatous infiltrate with a diffuse growth pattern, which extended into the subcutis. The Grenz zone was present. No signs of necrosis, karyorrhexis, hemophagocytosis, or angiocentric infiltrate were found (Fig. 2a). The tumor was composed of medium-sized pleomorphic cells with dispersed chromatin and absent or indistinct nucleoli, resembling lymphoblasts. Frequent mitosis was seen (Fig. 2b). Immunohistochemical studies revealed the reactivity of more than 90% of the cells with CD56, CD4, and CD43 (Fig. 3a, b). Immunostaining for CD3, CD8, CD20, CD30, CD68, CD79a, CD99, T-cell intracellular antigen-1 (TIA-1), Gallyas-Braak silver (GB), L26, Kp-1, myeloperoxidase (MPO), and terminal deoxynucleotidyl transferase (TdT) was either weak or negative. Clonal rearrangement of the T-cell receptor (TCR) was not detected by polymerase chain reaction (PCR). Epstein-Barr virus (EBV) staining of the skin biopsy specimen was negative. Laboratory examinations, including complete blood examination with peripheral blood smear, liver enzymes, electrolyte levels, kidney function, antinuclear antibody, and urine analysis, were all normal. EBV antibodies were negative. Chest radiograph, nasal bone X-ray, and bone marrow biopsy revealed no abnormal findings. Computed tomography of the nasal cavity, abdomen, and pelvis was normal. On the basis of the aforementioned clinical, histopathologic, and immunohistochemical findings, the patient was diagnosed with primary cutaneous CD4(+)/CD56(+) hematodermic neoplasm [ blastic natural killer (NK)-cell lymphoma]. After receiving a diagnosis of a very aggressive malignancy, the patient refused chemotherapy until right groin lymphadenopathy occurred 6 months later. In February 2007, the lesion was excised and showed the same pathologic features, consistent with cutaneous blastic NK-cell lymphoma. From March 2007, the patient received five courses of polychemotherapy with cyclophosphamide, adriamycin, vincristine, and prednisolone (CHOP). The lymphadenopathy disappeared after one cycle of chemotherapy. The patient received four more cycles of chemotherapy and no recurrence was observed over the following 6 months.
引用
收藏
页码:62 / 65
页数:4
相关论文
共 50 条
  • [1] Primary cutaneous CD4+/CD56+ hematodermic neoplasm (blastic NK-cell lymphoma): a report of five cases
    Ng, Ashley P.
    Lade, Stephen
    Rutherford, Timothy
    McCormack, Christopher
    Prince, H. Miles
    Westerman, David A.
    HAEMATOLOGICA, 2006, 91 (01) : 143 - 144
  • [2] CD4+/CD56+hematodermic neoplasm (blastic NK-cell lymphoma)
    Weaver, Joshua
    Hsi, Eric D.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2008, 35 (10) : 975 - 977
  • [3] The utility of gemcitabine and vinorelbine in patients with blastic NK lymphoma (CD4+/CD56+ hematodermic neoplasm).
    Ellis, LR
    Horwitz, SM
    BLOOD, 2005, 106 (11) : 268B - 268B
  • [4] CD4+/CD56+ hematodermic neoplasm:: Blastic NK cell lymphoma in a 6-year-old child
    Eguaras, Ann Veronique C.
    Lo, Raymundo W.
    Veloso, Januario D.
    Tan, Vivian Grace
    Enriquez, Ma. Luisa D.
    Del Rosario, Ma. Luz U.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2007, 29 (11) : 766 - 769
  • [5] CD4+ and CD56+ hematodermic neoplasm
    不详
    JOURNAL OF CUTANEOUS PATHOLOGY, 2006, 33 (01) : 115 - 115
  • [6] Agranular CD4+ CD56+ hernatodermic neoplasm (blastic NK-cell lymphoma) revealed by cutaneous localization:: 2 cases.
    Machet, L
    De Muret, A
    Wiezberka, E
    Bernez, A
    Abdallah-Lotf, M
    Linassier, C
    Petrella, T
    ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE, 2004, 131 (11): : 969 - 973
  • [7] CD4+/CD56+ hematodermic neoplasm
    Carlesimo, Marta
    Mari, Elena
    Cortesi, Giorgia
    Orsini, Diego
    Narcisi, Alessandra
    Cox, Maria Cristina
    Ruco, Luigi
    Pulcini, Federica
    Camplone, Germana
    EUROPEAN JOURNAL OF DERMATOLOGY, 2011, 21 (02) : 291 - 292
  • [8] CD4+/CD56+ HEMATODERMIC NEOPLASM
    Tatum, C.
    McCall, C.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2009, 36 (01) : 157 - 157
  • [9] A case of primary cutaneous CD56+, TdT+, CD4+, blastic NK-cell lymphoma in a 19-year-old woman
    Chang, SE
    Choi, HJ
    Huh, J
    Choi, JH
    Sung, KJ
    Moon, KC
    Koh, JK
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2002, 24 (01) : 72 - 75
  • [10] CD4+ CD56+ Hematodermic Neoplasm Without Cutaneous Involvement
    Seema Sharma
    Chanchal Rana
    Indian Journal of Hematology and Blood Transfusion, 2014, 30 : 1 - 3